Skip to content

OS Therapies OSTX Total Assets

Total Assets at other companies

Immunome logo
ImmunomeIMNM
$619.79M+80.9%
CTO
Citius Oncology, Inc.CTOR
$100.7M+10.1%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$99.89M-27.9%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$997M-13.8%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$646.64M+113%
WHW
Whitehawk Therapeutics, Inc. Common StockWHWK
$127.23M-45.6%

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+66.4%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's total assets?
OS Therapies (OSTX) reported total assets of $7.3M in Q1 2026.
How has OS Therapies's total assets changed year-over-year?
OS Therapies's total assets increased by 71.7% year-over-year, from $4.25M to $7.3M.
What is the long-term trend for OS Therapies's total assets?
Over 2 years (2023 to 2025), OS Therapies's total assets has grown at a 192.7% compound annual growth rate (CAGR), from $798.08K to $6.84M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.